The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Large versus limited molecular profiling panel screening program in patients with metastatic sarcoma: An exploratory subgroup analysis from the ProfiLER 02 trial.
 
Mehdi Brahmi
Honoraria - Deciphera; PharmaMar
Consulting or Advisory Role - Deciphera
Travel, Accommodations, Expenses - PharmaMar
 
Olivier Tredan
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe; Gilead Sciences; Lilly; MSD Oncology; Pfizer; Pierre Fabre; Roche; Sandoz-Novartis; Seagen; Stemline Therapeutics; Viatris
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; MSD Oncology; Novartis; Pfizer; Roche
 
Nicolas Penel
Research Funding - Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Christine Chevreau
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Ipsen; Pfizer
Travel, Accommodations, Expenses - Ipsen
 
Christophe Perrin
Honoraria - Boehringer Ingelheim; GlaxoSmithKline
Travel, Accommodations, Expenses - MSD Oncology; PharmaMar
 
Nelly Firmin
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
Francois Bertucci
No Relationships to Disclose
 
Valéry Attignon
No Relationships to Disclose
 
Pierre Saintigny
Honoraria - Archer; Bristol Myer Squibb; HTG Molecular Diagnostics; Inivata; Roche Molecular Diagnostics
Research Funding - AstraZeneca; BMS Foundation; Illumina; Novartis; Omicure (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myer Squibb; Illumina; Roche
 
Isabelle Treilleux
No Relationships to Disclose
 
Sylvie Chabaud
No Relationships to Disclose
 
Gwenaelle Garin
No Relationships to Disclose
 
David Pérol
Honoraria - AstraZeneca; BMS; DAIICHI SANKYO; Lilly; MSD; Novartis; Roche; TAKEDA
Travel, Accommodations, Expenses - Roche
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; Karyopharm Therapeutics; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Armelle Dufresne
Travel, Accommodations, Expenses - PharmaMar